LSEH: Life Science Excellence Hub - prot. A0320-2019-28196

Within an aggregate composed of National Research Council, National Institute of Health, Catholic University of the Sacred Heart, Italian Institute of Technology Foundation and coordinated by Sapienza University of Rome(Key Mandatory Research Body), the Campus Bio-Medico University of Rome participates in 7 research and industrial development projectsin collaboration with companies. 

The objective of the LSEH project is the transfer of knowledge and technology to make the regional ecosystem competitive and a bearer of innovation on a national and European scale in the Life Sciences sector.

Overall budget of the LSEH project: € 320.580,01 - Regional funding of the LSEH project: € 320.580,01

The 7 projects with UCBM participation

>> SMILE project - prot. A0320-2019-28107The SMILE project aims to develop a wearable and non-invasive system for continuous and real-time monitoring of heart rate, breathing and sweating, in work and sports environments. The innovative solution is based on the use of wireless wearable sensors and on the development of software aimed at integrating the data collected while respecting privacy requirements. The objective is to provide feedback on the user's well-being, early identifying potential critical and/or pathological conditions. The project was born from the collaboration between the Department of IngAstronautical, Electrical and Energy Engineering (DIET) of the Sapienza University of Rome, the Bio-Medical Campus of Rome (UCBM) and the company Integris SpA. In addition, it will make use of the external support of INAIL. Project partners: Integris, Sapienza (DIAEE), UCBMOverall budget: €481.251,50 Regional funding: €324.899,95 Research unit UCBM involved: Neurophysiology and Neuroingengineering of Human‐Technology interaction Biomedical Measurements and Instrumentation Anesthesia, Resuscitation and Pain Medicine
>> HeAL 9000 project - prot. A0320-2019-28108The project proposes the creation of a "service robot" active in the context of orthopedic rehabilitation therapy. Specific cognitive and physical interaction capabilities will make the Robot capable of: (i) observing, perceiving the surrounding environment and learning new behaviours, (ii) physically interacting with people and objects, adapting to the context, (iii) monitoring and communicating with the patient, make autonomous decisions through the mechanisms of perception and learning developed. Project partners: Reveal, Exprivia, UCBMOverall budget: €494.076,55 Regional funding: €310.916,30 Research unit UCBM involved:Advanced Robotics and Person-Centered TechnologiesPhysical and Rehabilitation Medicine
>> INTSEPS Project - prot. A320-2019-28191Within the Life Sciences Area (ERC LS6_7 Microbiology sector), the Project aims to create an integrated microbiological diagnosis device for sepsis, a syndrome that affects millions of people and causes as many deaths around the world. Starting from the analysis of a singOnly a blood sample from the patient, the device will allow obtaining a rapid result both on the microbe causing the infection and on the profile of the patient's immune response to the infection. Project partner: Sapienza University of Rome, COMPANY Nurex SRL, Università Cattolica del Sacro Heart, Università Campus Bio-Medico di RomaOverall budget: €453.103,50 Regional funding: €307.873,60 Research unit UCBM involved: Applied bacteriological sciences Virology
>> TRUST-ME project - prot. A0320-2019-28192The TRUST-ME project, Rapid test on urine, blood or saliva with biosensors for the diagnosis of infectious diseases, aims to create medical devices based on the use of a biosensor capable of identifying the presence in biological liquids in a few minutes of antigens or antibodies of clinical interest, indicative of infectious disease or vaccine protection. In particular, rapid and inexpensive methods will be studied in the "point of care" setting for the diagnosis of important viral infections such as those caused by Measles, West Nile Fever and JC Polyomavirus, bacterial, such as those caused by Mycobacteriun tuberculosis and Streptococcus pneumoniae, as well as parasitic, such as malaria.Project partners: Biosensor, ISS, UCBM, SAPIENZA Overall budget: € 385.827,99 Regional funding: € 344.082,48 Units UCBM involved: Applied bacteriological sciences Virology
>> DHelp4H project - prot. A0320-2019-28109The DHelp4H project integrates multidisciplinary skills ingneurophysiological medical IT engineering for the creation of an e-community in the healthcare sector through a new Digital Helper product - EIMe4H ADAM - which enables ingbiomedical engineers in the rapid development of web/mobile applications based on Instant Messaginging and Chatbot.Project partner: Webmonks, CNR, UCBMOverall budget: €313.299,20 Regional funding: €231.385,12 Research unit UCBM involved: Processing Systems and Bioinformatics Neurology, Neurophysiology, Neurobiology
>> PISTIS project - prot. A0320-2019-28116Innovative platform for the harmonization of the everyday life of weak subjects in the relationship with the advanced age and the interaction with their living spaceThe aim of the project is to improve the quality of life of weak subjects (elderly, patients with chronic diseases, etc. ) through the implementation of an innovative technological platform which through the synergistic use of sensors, telemedicine, voice assistant, IoT home automation and computer vision is able to harmonize the home environment making it a virtual caregiver. Project partners: Altintech, PPONE , UCBM, Sapienza Overall budget: € 539.465,25 Regional funding: € 361.030,14 Research unit UCBM involved:IngTissue and chemical engineering forIngEngineeringMeasurements and Biomedical Instrumentation
>> ITHACA Project - prot. A0320-2019-28177
The project was selected among the 6 projects that best met the LSEH criteria. For UCBM the staff involved in the project are: prof. Alberto Rainer, professor Marcella Trombetta, ing. Sara M. Giannitelli, Dr Franca Abbruzzese, Dr Valentina Peluzzi.Integration of High-throughput Technologies for the screening rapid development of Antibodies for Antitumor therapiesThe ITHACA project was born from the collaboration between Takis, Campus Biomedico University and CNR whose objective is the creation of highly innovative and efficient microfluidic systems for the identification of monoclonal antibodies for the treatment of tumors. The objective will be pursued through two main activities: Create and integrate into the research and development process of monoclonal antibodies a microfluidic system to identify and select the cells (hybridomas or B cells) that produce specific antibodies for a specific tumor. Create in the laboratory a microfluidic system to measure the activity of the antibodies produced, thanks to an organ-on-chip approach, to select the antibody with the greatest therapeutic efficacy. Project partners: Takis, CNR, UCBMOverall budget: €581.990,78 Regional funding: €416.810,64 Research unit UCBM involved:IngTissue and chemical engineering forIngengineering

>> February 2023 Update - Life Science Excellence Hub